Le Lézard
Classified in: Health, Science and technology
Subject: SVY

Viral Vector and Plasmid DNA Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027


NEW YORK, May 21, 2019 /PRNewswire/ --

Viral Vector & Plasmid DNA Manufacturing Market: Overview
This report analyzes the current and future scenario of the global viral vector & plasmid DNA manufacturing market for the period 2019 to 2027. Increase in prevalence and incidence rates of cancer, genetic disorders and infectious diseases, high unmet needs in patients with rare disorders, and raised acceptance for comparatively newer treatment options in developing countries are likely to be major drivers of the global viral vector & plasmid DNA manufacturing market during the forecast period.



Read the full report: https://www.reportlinker.com/p05775478/?utm_source=PRN



The viral vector & plasmid DNA manufacturing market report comprises an elaborate executive summary, including a snapshot that provides information on various segments of the market.It also provides information and data analysis of the global market with respect to segments based on type, application, disease, end-user, and region.

A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section.Additionally, the section comprises competitive matrix and profiles of key market players, along with business overview, to project the competitive landscape of the market.

The section also provides market attractiveness analysis based on region and market share analysis in terms of key players, thereby presenting a thorough analysis of the overall competitive scenario in the viral vector & plasmid DNA manufacturing market.

Viral Vector & Plasmid DNA Manufacturing Market: Key Segments
Based on type, the global viral vector & plasmid DNA manufacturing market has been segmented into lentivirus, adenovirus, adeno-Associated Virus (AAV), plasmid DNA, and others.In terms of application, the global viral vector & plasmid DNA manufacturing market has been divided into gene therapy, vaccinology, and others.

Based on disease, the market has been segregated into genetic disorders, cancer, infectious disease, and others.In terms of end-user, the market has been bifurcated into biotech companies and research institutes.

The market size and forecast for each of these segments have been provided for the period 2019 to 2027, along with their respective CAGR for the forecast period 2017 to 2027, considering 2018 as the base year.

Viral Vector & Plasmid DNA Manufacturing Market: Regional Outlook
In terms of region, the global viral vector & plasmid DNA manufacturing market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). Market size and forecast for each of these regions and the mentioned countries have been provided for the period 2019 to 2027, along with their respective CAGR for the forecast period 2017 to 2027, considering 2018 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in the Report
The report also profiles major players operating in the global viral vector & plasmid DNA manufacturing market based on various attributes, such as company overview, financial overview, product portfolio, business strategies, and recent developments. The players covered in the report include CobraBiologics, Novasep Inc., Cell and Gene Therapy Catapult, Kaneka Eurogentec S.A., FUJIFILM Diosynth Biotechnologies Inc., Spark Therapeutics, Inc. Merck KGaA, uniQure N.V., and Lonza. The global viral vector & plasmid DNA manufacturing market has been segmented as below:

Viral Vector & Plasmid DNA Manufacturing Market, by Type
Lentivirus
Adenovirus
Adeno-Associated Virus (AAV)
Plasmid DNA
Others

Viral Vector & Plasmid DNA Manufacturing Market, by Application
Gene Therapy
Vaccinology
Others

Viral Vector & Plasmid DNA Manufacturing Market, by Disease
Genetic Disorders
Cancer
Infectious Disease
Others
Viral Vector & Plasmid DNA Manufacturing Market , by End-user
Biotech Companies
Research Institutes

Viral Vector & Plasmid DNA Manufacturing Market, by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Rest of Middle East & Africa

Read the full report: https://www.reportlinker.com/p05775478/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

19 jui 2019
The highly anticipated Microsoft Inspire 2019 was held on July 14-18, 2019.  At the conference, 21Vianet Blue Cloud (hereafter "21V Blue Cloud") announced their new solution partners and introduced the AggreSmart solution platform (public preview) to...

19 jui 2019
HyperBlock Inc. ("HyperBlock" or the "Company") confirmed today that the first batch of a US $1.1M shipment of Bitmain's new 7nm Bitcoin mining servers has arrived on North American shores. HyperBlock expects to fully deploy the new servers this...

19 jui 2019
This Saturday 20 July, The Aldrin Family Foundation will host a free family celebration with The People's Moon transforming New York's Times Square into Tranquillity base celebrating the 50th Anniversary of when humans first walked on the Moon taking...

19 jui 2019
Laboratory Medicine Consultants, Ltd. ("LMC") has been informed by Retrieval Masters Creditors Bureau d/b/a American Medical Collection Agency ("AMCA") of a data security incident involving the AMCA payment website. AMCA is an independent collection...

19 jui 2019
Western Pathology Consultants, Ltd. ("Western Pathology") has been informed by Retrieval Masters Creditors Bureau d/b/a American Medical Collection Agency ("AMCA") of a data security incident involving the AMCA payment website. AMCA is an independent...

19 jui 2019
South Texas Dermatopathology, PLLC has been informed by Retrieval Masters Creditors Bureau d/b/a American Medical Collection Agency ("AMCA") of a data security incident involving the AMCA payment website. AMCA is an independent collection agency that...



News published on 21 may 2019 at 20:02 and distributed by: